Tải bản đầy đủ (.pdf) (7 trang)

MSDS LNMO 12031 75 3 102516

Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (557.23 KB, 7 trang )

conditions.
Possibility of hazardous reactions
No data available
Conditions to avoid
No data available
Incompatible materials
Oxidizing agents
Hazardous decomposition products
Hazardous decomposition products formed under fire conditions. - Nickel/nickel oxides, Lithium oxides,
Manganese/manganese oxides
Other decomposition products - no data available
In the event of fire: see section 5

Toxicological Information
Information on toxicological effects
Acute toxicity
No data available
Inhalation: No data available
Dermal: No data available
Skin corrosion/irritation
No data available
Serious eye damage/eye irritation
No data available
Respiratory or skin sensitization
No data available
Germ cell mutagenicity
No data available
Carcinogenicity
Limited evidence of carcinogenicity in human studies
IARC:


No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
ACGIH: No component of this product present at levels greater than or equal to 0.1% is identified as a
carcinogen or potential carcinogen by ACGIH.
NTP: No component of this product present at levels greater than or equal to 0.1% is identified as a
known or anticipated carcinogen by NTP.
OSHA: No component of this product present at levels greater than or equal to 0.1% is identified as a
carcinogen or potential carcinogen by OSHA.
Reproductive toxicity
No data available
Specific target organ toxicity - single exposure
No data available
MTI Corporation

5

Safety Data Sheet


Lithium Manganese Nickel Oxide (LNMO)
Revision Date: Oct 2015
Specific target organ toxicity - repeated exposure
No data available
Aspiration hazard
No data available
Additional Information
RTECS: Not available
Large doses of lithium ion have caused dizziness and prostration, and can cause kidney damage if sodium
intake is limited. Dehydration, weight loss, dermatological effects, and thyroid disturbances have been
reported. Central nervous system effects that include slurred speech, blurred vision, sensory loss, ataxia,

and convulsions may occur. Diarrhea, vomiting, and neuromuscular effects such as tremor, clonus, and
hyperactive reflexes may occur as a result of repeated exposure to lithium ion., Men exposed to manganese
dusts showed a decrease in fertility. Chronic manganese poisoning primarily involves the central nervous
system. Early symptoms include languor, sleepiness and weakness in the legs. A stolid mask-like
appearance of the face, emotional disturbances such as uncontrollable laughter and a spastic gait with
tendency to fall in walking are findings in more advanced cases. High incidence of pneumonia has been
found in workers exposed to the dust or fume of some manganese compounds.
Stomach - Irregularities - Based on Human Evidence

12.
12.1
12.2
12.3
12.4
12.5
12.6

13.
13.1

14.

Ecological Information
Toxicity
No data available
Persistence and degradability
No data available
Bioaccumulative potential
No data available
Mobility in soil

No data available
Results of PBT and vPvB assessment
PBT/vPvB assessment not available as chemical safety assessment not required/not conducted.
Other adverse effects
No data available

Disposal Considerations
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Contact a licensed professional
waste disposal service to dispose of this material. Dissolve or mix the material with a combustible solvent
and burn in a chemical incinerator equipped with an afterburner and scrubber.
Contaminated packaging
Dispose of as unused product.

Transport Information
DOT (US)
Not dangerous goods
IMDG
Not dangerous goods

MTI Corporation

6

Safety Data Sheet


Lithium Manganese Nickel Oxide (LNMO)
IATA

Not dangerous goods

15.

Revision Date: Oct 2015

Regulatory Information
SARA 302 Components
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section 302.
SARA 313 Components
This material does not contain any chemical components with known CAS numbers that exceed the
threshold (De Minimis) reporting levels established by SARA Title III, Section 313.
SARA 311/312 Hazards
Acute Health Hazard, Chronic Health Hazard
Massachusetts Right to Know Components
No components are subject to the Massachusetts Right to Know Act.
Pennsylvania Right to Know Components
CAS-No.
Revision Date
Lithium Manganese Nickel Oxide
12031-75-3
New Jersey Right to Know Components
Lithium Manganese Nickel Oxide
12031-75-3
California Prop. 65 Components
WARNING: This product contains a chemical known to the State of California to cause birth defects or other
reproductive harm.

16.


Other Information

Full text of H-Statements referred to under sections 2 and 3.
Carc. Carcinogenicity
H317 May cause an allergic skin reaction.
H351 Suspected of causing cancer.
Skin Sens. Skin sensitization
Further information
The information above is believed to be accurate and represents the best information currently available to us.
However, it does not represent any guarantee of the properties of the product. We make no warranty of
merchantability or any other warranty, express or implied, with respect to such information, and we shall not be
held liable for any damage resulting from handling or from contact with the above product. Users should make
their own investigations to determine the suitability of the information for their particular purposes.

MTI Corporation

7

Safety Data Sheet



Tài liệu bạn tìm kiếm đã sẵn sàng tải về

Tải bản đầy đủ ngay
×